By using our website, you agree to the use of cookies as described in our Cookie Policy.

Close
Consilium-white-out.png Consilium Final logo.png Menu
Close
Twitter
  • About Us
    • Healthcare
    • Our values
  • Our expertise
    • Overview
      • Overview
    • Our experience
    • Case studies
      • Alliance for Regenerative Medicine
      • Sensyne Health
      • Cancer Research UK
      • Cambridge Innovation Capital
      • Vectura
      • CMR Surgical
      • Horizon Discovery
      • Immunocore
      • Quanta
  • Our team
  • News & insights
    • Consilium news
    • Consilium Conscience
    • Monthly intel
    • Events calendar
    • Email Alerts
  • Careers
  • Contact us

Healthcare newsletter

  • Home/
  • News & insights/
  • Monthly intel/
  • Newsletter

News & insights

  • Consilium news
  • Consilium Conscience
  • Monthly intel
  • Events calendar
  • Email Alerts
Tweets by ConsiliumHC

Skip to our monthly intel

What’s new? Recently returned COO Ivar Milligan muses on the team workings that make Consilium the success it is.

By Ivar Milligan, Chief Operating Officer 

I’m amazed (but not surprised) at the developments and growth that have occurred in the couple of years that I was away from Consilium; the demand for Consilium’s services continues to increase and the team has grown in scale and capability to provide our excellent service to new and long-served clients. This growth is the reason for my new role and one of my areas of focus is to look to develop the team further by bringing in some of the most talented communicators from financial PR, healthcare and beyond. One of our strengths is the variety in backgrounds and experiences that our team has, and assembling advisory teams for clients to make the most of these. Despite this growth, the company’s culture, thanks to the firm being independent, has been able to retain its agility, enabling the management team to respond quickly to both clients’ and employees’ needs in a time when this is ever more important.

It is unsurprising that Consilium’s way of working has changed dramatically over the past 12 months and it is evident that the exposed strength of this team is its willingness to support and care for each other. The push to enable remote socialising and the opportunity to discuss what really matters to individuals on a daily basis has brought pastoral care to the fore and it’s refreshing to see that the relationships developed in the office, especially with new joiners, can be replicated through time on the phone or a walk through a London park. A noticeable development in the past year has been the awareness of needing time away from screens and desks; enabling a proper break in the middle of the day which is enforced and kept protected by all staff between 12:30-1:30 pm daily, and a clear cut off to routine calls and emails at 6:00 pm whilst invigorating our focus on work yet still allowing our team to respond to the urgent needs of our clients out of hours.

Our internal mentoring and training continues apace and it's gratifying to see that reflected in recent promotions and those being worked towards. It will be interesting to see how this team cohesion is affected by our return to the office; I wouldn’t be surprised if it catalyses a surge in further successes as ways of working ease back to normality. We all look forward to exploiting the best of home and office working, and to spending more time with our clients; in person.

Get the latest company updates from Consilium:

LinkedIn

Movers and Shakers

See the latest City movers and shakers

close

Movers and Shakers

  • OncoDNA appointed Bernard Courtieu as CEO
  • SparingVision appointed Daniel C. Chung as CMO
  • QuantumMDx appointed Diran Guiliguian as CCO
  • Abingdon Health appointed Melanie Ross as CFO
  • Sensyne Health appointed Hina Zaman as Managing Director of its Healthcare Division and Martin Gouldstone as CBO of its Life Science Division
  • CMR Surgical appointed Catherine Moukheibir as Non-Executive Director
  • Moderna appointed Corinne Le Goff as CCO
  • Eli Lilly appointed Anat Ashkenazi as CFO
  • Amylyx Pharmaceuticals appointed James Frates as CFO
  • Innocoll appointed Louis Pascarella as CEO
  • Valneva appointed Perry Celentano as interim COO
  • eFFECTOR Therapeutics appointed Mike Byrnes as CFO
  • BiondVax Pharmaceuticals appointed Amir Reichman as CEO
  • Avrobio appointed Diana Escolar as CMO
  • Blink Science appointed Eric Doherty as President
  • Viridian Therapeutics appointed Jonathan Violin as President and CEO
  • NexImmune appointed Robert Knight as CMO
  • Chiasma appointed John Doyle as CFO
  • Applied Molecular Transport appointed Douglas Rich as CTO
  • Imara appointed Kenneth Attie as Senior Vice President and CMO
  • Alector appointed Shehnaaz Suliman as interim CBO
  • Faze Medicines appointed Philip Vickers as CEO
  • Roivant appointed Matt Gline as CEO
  • Neurophth Biotechnology appointed Qiutang Li as CSO
  • Butterfly Netowork appointed Todd Fruchterman as President and CEO
  • MedPharm appointed Jon Lenn as CSO
  • KSQ Therapeutics appointed Qasim Rizvi as CEO
  • Connect Biopharma appointed Selwyn Ho as CBO
  • ViaCyte appointed Michael Yang as President and CEO
  • Cognito Therapeutics appointed Mark Day as CBO
  • MOMA Therapeutics appointed Asit Parikh as President and CEO
  • Actimed Therapeutics appointed Frank Misselwitz as CMO
  • Novo Nordisk appointed Marcus Schindler as CSO and Executive Vice President for early R&D
  • Worldwide Clinical Trials appointed Brian Tuttle as CFO
  • Catamaran Bio has appointed Alvin Shih as CEO
  • Merck & Co appointed Robert Davies as CEO
  • Tissium appointed Hunt Henrie as CBO
  • CRISPR Therapeutics appointed Philippe Drouet as CCO
  • OncoNano Medicine appointed Martin Discoll as CEO
  • Quanticate appointed Lee Patterson as COO
  • Trevi Therapeutics appointed William Forbes as CDO
  • Cervance appointed Carrie Ann Cook as CBO
  • OncoSec appointed Brian Leuthner as COO
  • Arcellx Inc. appointed Rami Elghandour as Chairman and CEO
  • Avidity Biosciences Inc. appointed Michael Flanagan as CTO
  • Egetis Therapeutics AB appointed Peder Sven Walberg as CMO and Director
  • Omeros Corp. appointed Nadia Dac as CCO
  • Papa & Barkley Essentials LLC appointed Evelyn Wang as CEO
  • SynAct Pharma AB appointed Thomas Boesen as COO
  • Evolve Biologics, Inc. appointed James V. Caggiano as CEO
  • Ironwood Pharmaceuticals appointed Tom McCourt as interim CEO
  • Oasmia Pharmaceutical AB appointed Dr. Heidi B. Ramstad as CMO

Fundraising highlights

Highlighted fundraising activity this month

close

Fundraising highlights

Company Name

Amount Raised

Type of Fundraise

Country

Date

Public company financings

Faron Pharmaceuticals

€15 million

Private placement

Finland

12-Feb-21

Sana Biotechnology

$675.6 million

IPO

US

9-Feb-21

Argenx S.E.

$1 billion

Follow-on

Netherlands

3-Feb-21

MaxCyte

$55 million

Crossover

US

2-Feb-21

CureVac N.V.

$450 million

Follow-on

Germany

28-Jan-21

Sensei Biotherapeutics Inc.

$30 million

Undisclosed

US

12-Jan-21

Cullinan Oncology LLC

$287.4 million

IPO

US

12-Jan-21

Private company Financings

Rubix LS

$1.3 million

Seed

US

10-Feb-21

Pan Cancer TBV

Undisclosed

Seed

Netherlands

10-Feb-21

Anticancer Bioscience

£9.8 million

Undisclosed

China

10-Feb-21

Drug Farm

$56 million

Undisclosed

US/China

10-Feb-21

Inivata

$35 million

Series C

UK

4-Feb-21

Reverie Labs

$25 million

Series A

US

3-Feb-21

SpectraWave

$13.2 million

Series A-2

US

3-Feb-21

Cellino

$16 million

Seed

US

1-Feb-21

Parse Biotechnologies Inc.

$7 million

Series A

US

28-Jan-21

Enthera Pharmaceuticals

$42.5 million

Series A

Italy

28-Jan-21

Ukko Inc.

$40 million

Series B

Israel

28-Jan-21

Encodia

$75 million

Series C

US

28-Jan-21

Design Therapeutics

$125 million

Series B

US

28-Jan-21

TScan Therapeutics

$100 million

Series C

US

25-Jan-21

reMYND NV

$28.9 million

Series B

Belgium

21-Jan-21

Ikaxa Ltd.

$54.1 million

Undisclosed

UK

20-Jan-21

Verve Therapeutics

$94 million

Series B

US

19-Jan-21

NewAmsterdam Pharma

$196 million

Series A

Netherlands

15-Jan-21

IO Biotech

$127 million

Series B

Denmark

14-Jan-21

Delfi Diagnostics

$100 million

Series A

US

13-Jan-21

Valo Health LLC

$190 million

Series B

US

12-Jan-21

Visen Pharmaceuticals

$150 million

Series B

China

12-Jan-21

NuProbe Inc.

$42 million

Undisclosed

US/China

12-Jan-21

EQRx

$500 million

Series B

US

12-Jan-21

Scorpion Therapeutics Inc.

$162 million

Series B

US

8-Jan-21

Analyst directory

View our Analyst Directory

close

Analyst directory

Bank

Analyst

ABG Sundal Collier

Morten Larsen, Daniel Thorsson

ABN AMRO

Mark van der Geest, Rene Verhoeff

Alm. Brand Markets

Michael Friis Jørgensen

AlphaValue

Armelle Moulin, Marion Scherzinger

Banco de Sabadell, S.A.

Javier Esteban

Banco Espirito Santo de Investimento

Luis Navia

Bank am Bellevue

Bruno Eschli, Stephen Leventhal

Bankhaus Lampe KG

Heiko Feber, Frank Neumann

Bank Vontobel AG

Carla Baenziger

Barclays

Hassan Al-Wakeel, Blanka Porkolab, Emily Field, Jameel Bakhsh, Brian Balchin, Peter Lawson

Berenberg Bank

Scott Bardo, Luisa Hector, Kerry Holford, Tom Jones, Ravi Misra, Xian Deng, Michael Healy, Esther Hong, Iris Zhilin Long, Zhiqiang Shu, Yun Zhong (David Hogg)

Bank of America Merrill Lynch

Aspen Mori (NY), Graham Parry (London), Qian Weng, John Aldersley (Dan Lundquist)

Bryan, Garnier & Co

Dylan van Haaften, Eric Le Berrigaud, Olga Smolentseva, Victor Floc’h, Jean Jacques Le Fur, (Dominic Wilson)

CA Cheuvreux

Marcel Brand, Laurent Flamme, Richard Koch, Oliver Reinberg

Caja Madrid Bolsa

Ana Isabel González García

Carnegie Bank

Niels Granholm, Philip Lagnetoft, Kristofer Liljeberg-Svensson, Carsten Lonborg Madsen, Henrik Sinding, Lars Topholm

Cenkos Securities

Chris Donnellan

Citigroup

Liav Abraham (US), Andrew Baum, Alex Glasner, Peter Verdult, Patrick Wood, (David Rawley)

CM-CIC Securities

Agnès Blazy, Arsene Guekam

Commerzbank

Volker Braun, Daniel Wendorff

Cowen International

David Kirkpatrick, Ritu Baral, Ryan Blicker, Ken Cacciatore, Marc Frahm, Joshua Jennings, Chris Lin, Charles Rhyee, Doug Schenkel, Yaron Weber

Credit Suisse

Christoph Gretler, Evan Seigerman, Matt Miksic Barbora Blaha, Jo Walton, Matthew Weston, (Phil Gestrin)

Danske Equities

Thomas Bowers, Mattias Häggblom, Hans Jeppsson, Martin Parkhøi, Søren Samsøe

Deutsche Bank

Emmanuel Papadakis, Rajan Sharma, Justin Bowers, Jack McKibben, Farzana Habib, Katie Kraft, Jeremy Finkelstein, Andrew Vincent

Degroof Petercam

Thomas Guillot, Benoit Louage, Chris Keepers

DnB NOR

Rune Dahl

DZ Bank

Christa Bähr, Elmar Kraus, Thomas Maul, Peter Spengler

Edison

John Priestner, Susie Jana, John Savin, Jonas Peciulis, Sean Conroy, Maxim Jacobs, Nathaniel Calloway

, Pooya Hemami

Equinet Institutional Services

Edouard Aubery

Equity Development

Emma Ulker

Exane BNP Paribas

Richard Parkes, Alex Evans, Julien Dormois, Hugo Solvet, Nicolas Langlet, Kartik Swaminathan

fairesearch GmhH & Co

Martin Schnee

finnCap

Mark Brewer, Arshad Ahad, Nik Lysiuk

Goetz Partners

Melina Reisenberg, Chris Redhead

Goldman Sachs

Krishna-Chaitanya Arikatla, Veronika Dubajova, Divya Harikesh, Keyur Parekh, Graig Suvannavejh, Joanna Tucka, Kira Huppertz

Handelsbanken Capital Markets

Klaus Madsen, Björn Olander, Peter Sehested

Hardman and Co

Martin Hall, Gregoire Pave

Helvea

Daniel Jelovcan, Odile Rundquist, Olav Zilian

HSBC

Steve McGarry, Julie Mead, Lucy Acton, Murielle André-Pinard

ING

Sjoerd Ummels, David Vagman

Investec

Andrew Whitney, Jens Lindqvist, (Brough Ransom)

Jefferies

Harry Sephton, Grace Lee, Lucy Codrington, Philippa Gardner, Kit Lee, Ken Rumph, James Vane-Tempest, Peter Welford, Ing Shen Tan, Erin Primdahl, (Jan Scherer)

JP Morgan Cazenove

David Adlington, Alex Comer, James Gordon, Richard Vosser, Marjan Daeipour

KBC Securities

Sandra Cauwenberghs, Lenny Van Steenhuyse

Kempen & Co

Alexander Cogut, Rene Wouters, Suzanne van Voorthuizen, Ingrid Gafanhão, Sebastiaan van der Schoot

Kepler Capital Markets

Arsene Gekam, Damien Choplain, David Evans, Maja Pataki, Martin Voegtli,  Matthias Maenhaut

Landesbank Baden-Wuerttemberg

Timo Kuerschner

Liberum Capital

Alistair Campbell, Graham Doyle

Morgan Stanley

Alex Gibson, Michael Jungling, Simon Mather, Jenny Leeds, Cailin McGurk

N+1 Singer

Chris Glasper, Edward Thomason, Sahill Shan

Natixis Beatrice

Philipe Lanone, Jean-Jacques  Le Fur

Nordea Markets

Klas Pyk

Nord/LB

Holger Fechner, Thorsten Strauss

Numis

Paul Cuddon, Stefan Hamill, (Ceri Morgan)

Oddo Securities

 

Martial Descoutures, Oussama Denguir

Panmure Gordon

Mike Mitchell, Julie Simmonds, (David Cox)

Pareto Securities

Finlay Heppenstall, Ulrik Trattner

Peel Hunt

Miles Dixon, Anchal Verma, Amy Walker

Portzamparc Gestion S.A.

Christophe Dombu

RBC Capital Markets

Zoe Karamanoli (maternity), Charles Weston, Jack Reynolds-Clarke

Redburn

Simon Baker, Darshan R., Issie Kirby, Charles Pitman, Robert Shore, Ed Ridley-Day

Rx Securities

Samir Devani, Joseph Hedden, Michael King, Ross Blair

Sanford C Bernstein

Lisa Clive

Santander

Rebecca McClellan, Alejandro Conde Fraisolí, Tomasz Krukowski,

SEB Enskilda

Lars Hevreng, Henrik Simonsen, Peder Strand

Shore Capital

Adam Barker, Tara Raveendran

Société Générale

Florent Cespedes,

Patrick Jousseaume, Delphine Le Louët, Justin Smith

Standard & Poors

Sho Matsubara, Jacob Thrane

Stifel

Christian Glennie, Max Herrmann, James Osborne (Erland Sternby)

Swedbank

Johan Unnerus

Trinity Delta

Lala Gregorek, Franc Gregori

UBS

Laura Sutcliffe, Michael Leuchten, Jack Scannell, Sebastien Walker

Zürcher Kantonalbank

Michael Nawrath

Media directory

View our Media Directory

close

Media directory

BBC Fergus Walsh, Hugh Pym, James Gallagher, Katie Hope, Alex Therrien

Boston Business Journal Lucy Maffei, Don Seiffert, Max Stendahl

Boston Globe Jonathan Saltzman

Boston Herald Jordan Graham

Business Insider Erin Bromley, Lydia Ramsey, Zach Tracer, Marianne Guenot (US), Mia de Graaf (US)

Daily Express Mark Atherton, Becky Fletcher, Giles Sheldrick

Daily Mail Vanessa Chalmers, Jonathan Chadwick, Ethan Ennals, Anna Hodgekiss, Xantha Leatham, Fiona Macrae, Matt Oliver, Rachel Reilly, Alexandra Thompson, Sally Wardle, Victoria Woollaston, Shaun Wooller

Daily Telegraph, Julia Bradshaw, Laura Donnelly, Anne Gulland, Sarah Knapton, Chloe Lambert, Hannah Uttley, Hannah Boland, Jon Yeomans, Louise Moon

Financial Times Clive Cookson, Darren Dodd, Anna Gross, Donato Mancini, Sarah Neville, Gill Plimmer, Barney Thompson (UK); Hannah Kuchler (US)

Forbes Steve Brozak, Bruce Japsen, Leah Rosenbaum

Fortune Sy Mukherjee

Inc. Kimberly Weisul

Mail on Sunday Stephen Adams, Joanne Hart, Eve Simmons, Alex Lawson

Sky News Mark Kleinman, Paul Kelso, Thomas Moore

The Guardian Sarah Boseley, Denis Campbell, Hannah Devlin, Natalie Grover, Julia Kollewe, Linda Geddes

The New York Times Gina Kolata, Andrew Pollack, Alexandra Sifferlin, Sabrina Tavernise, Katie Thomas

The Sunday Times John Collingridge, Andrew Gregory, Jonathan Leake, Sabah Meddings, Lois Rogers, Oliver Shah, Ben Spencer, Jamie Nimmo

The Times Philip Aldrick, Kaya Burgess, James Dean, Richard Fletcher, Tom Howard, Graham Ruddick, Kat Lay, Fiona MacRae, Alex Ralph, Dominic Walsh, James Dean, Callum Jones (US)  

The Wall Street Journal Brian Gormley, Daniela Hernandez, Jared Hopkins (US); Robert Lee Hotz, Stefanie Ilgenfritz, Peter Loftus (US); Amy Dockser Marcus, Jonathan Rockoff (US); Denise Roland (Europe, maternity leave);, Joseph Walker, Jeanne Whalen (EU), Anna Wilde Mathews (US), Julie Wernau

The Washington Post Carolyn Johnson

S&P Global Etain Lavelle, Kristen Hallam

 

APM Health Europe Nick Hudson, Thomas Meek, Natalie Morrison, Eliza Slawther

Associated Press Tom Murphy

Bloomberg Naomi Kresge (Berlin); Albertina Torsoli (Geneva); John Lauerman (Boston), James Paton (London); Drew Armstrong (New York); Marthe Fourcade (Paris); Tim Loh (Munich)

Dow Jones Matteo Castia, Ian Walker, Philip Waller

fastFT Jennifer Thompson

Thomson Reuters Kate Kelland, Paul Sandle

 

AnimalPharm Joseph Harvey

BioCentury Stephen Hansen (UK); Jonathan Block, Paul Bonanos, Jeff Cranmer, Simone Fishburn, Dave Flores, Virginia Li, Chris Lieu, Lauren Martz, Erin McCallister, Alicia Parker, Susan Schaeffer, Mark Zipkin

BioWorld MedTech Bernard Banga, David Godkin, Larry Haimovitch, Stacy Lawrence, Nuala Moran, Katie Pfaff

BioWorld Shannon Ellis, Michael Fitzhugh, John Fox, Brian Orelli, Randy Osborne, Alfred Romann, Tamra Sami, Cormac Sheridan, Nuala Moran

Endpoints Arsalan Arif, John Carroll, Jason Mast, Amber Tong, Conner Mitchell

Genome Web Ben Butkus, Molika Ashford, Monica Heger, Madeleine Johnson

Fierce Life Sciences Ben Adams, Nick Paul Taylor (UK); Amirah Al Idrus, Michael Gibney, Conor Hale, Carly Helfand, Mark Hollmer, Emily Mullin, Eric Palmer, Tracy Staton, Emily Wasserman (US)

FirstWord Medtech Tina Tan

Healthcare Business International Max Hotopf

HealthInvestor Jonathan Bacon, Vernon Baxter, Sunniva Davies-Rommetveit, Catherine Llewllyn, Jenna Lomax, Ploy Radford

IN VIVO Lucie Ellis (UK); Ben Comer (US)

Investors Chronicle Harriet Clarfelt, Emma Powell, Mark Robinson

Labiotech Clara Rodríguez Fernández, Jonathan Smith

MedCityNews Alaric DeArment

MedNous Victoria English, Karen Finn

Medtech Insight Barnaby Pickering, Jenny Blair, Philip Greenfield (UK); Reed Miller (US)

Nature Biotechnology Lisa Melton

Pharmaphorum Catherine Longworth, Richard Staines, George Underwood

PharmaTimes Selina McKee, Anna Smith

Scrip John Davis, Kevin Grogan, Eleanor Malone, Andrew McConaghie, Alex Shimmings (UK); Joseph Haas, Mandy Jackson, Mary Jo Laffler, Jessica Merrill, Denise Peterson (US); Anju Ghangurde, Ian Haydock (Asia-Pacific)

Shares Magazine Martin Gamble

Sifted Michael Stothard, John Thornhill, Maija Palmer, Amy Lewin, Chris Sisserian, Isabel Woodford, Nicolas Colin, Kitty Knowles (UK), Mimi Billing, Tim Smith (Spain), Tom Turula (Sweden), Marie Mawad (France, maternity leave), Sian Bradley

STAT Mario Aguilar, Adam Feuerstein, Damian Garde, Matthew Herper, Meghana Keshavan, Katie Palmer, Rebecca Robbins, Ed Silverman

The Economist Catherine Brahic, Slavea Chankova, Alice Fulwood, Alok Jha, Natasha Loder

The Pink Sheet Neena Brizmohun, Francesca Bruce, Maureen Kenny, Ian Schofield, Vibha Sharma (UK); Nielsen Hobbs, Sue Sutter (US)

Timmerman Report Luke Timmerman

Vantage Lisa Urquhart, Madeleine Armstrong, Amy Brown, Elizabeth Cairns, Jacob Plieth (UK)

Xconomy Alex Lash, Frank Vinluan, Greg Huang


Back to previous page
Twitter
Register for news and updates Line
  • Twitter
  • LinkedIn
  • Email

©2021 Consilium Strategic Communications

  • Accessibility
  • Privacy and cookie policy
  • Sitemap

emperor.works